Single-arm multicenter phase II study on aggressive local consolidative therapy in combination with systemic chemotherapy for stage IV non-small cell lung carcinoma with oligometastases: CURE-OLIGO (TORG1529).

Radiat Oncol · 2025 · PMC11699676 · PMID 39755666

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

showed a trendno p-value reported

Several single-arm prospective studies and a meta-analysis of many retrospective studies revealed that patients with non-small cell lung carcinoma (NSCLC) with solitary and synchronous oligometastasis who received LCT and/or systemic chemotherapy showed a trend toward prolonged survival in subgroup analyses [ 7 – 10 ].

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.